KR20020090211A - 알키닐 치환된 프로피온산 유도체 및 당뇨병 및 비만에대한 그것의 사용 - Google Patents
알키닐 치환된 프로피온산 유도체 및 당뇨병 및 비만에대한 그것의 사용 Download PDFInfo
- Publication number
- KR20020090211A KR20020090211A KR1020027009399A KR20027009399A KR20020090211A KR 20020090211 A KR20020090211 A KR 20020090211A KR 1020027009399 A KR1020027009399 A KR 1020027009399A KR 20027009399 A KR20027009399 A KR 20027009399A KR 20020090211 A KR20020090211 A KR 20020090211A
- Authority
- KR
- South Korea
- Prior art keywords
- phenyl
- pent
- ynyloxy
- propionic acid
- ethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000137 | 2000-01-28 | ||
DKPA200000137 | 2000-01-28 | ||
DKPA200001065 | 2000-07-07 | ||
DKPA200001065 | 2000-07-07 | ||
DKPA200001593 | 2000-10-25 | ||
DKPA200001593 | 2000-10-25 | ||
PCT/DK2001/000057 WO2001055086A1 (en) | 2000-01-28 | 2001-01-26 | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20020090211A true KR20020090211A (ko) | 2002-11-30 |
Family
ID=27222337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027009399A KR20020090211A (ko) | 2000-01-28 | 2001-01-26 | 알키닐 치환된 프로피온산 유도체 및 당뇨병 및 비만에대한 그것의 사용 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1254102A1 (es) |
JP (1) | JP2003520839A (es) |
KR (1) | KR20020090211A (es) |
CN (1) | CN1396904A (es) |
AU (1) | AU2831801A (es) |
BR (1) | BR0107902A (es) |
CA (1) | CA2396372A1 (es) |
HU (1) | HUP0204247A3 (es) |
IL (1) | IL150259A0 (es) |
MX (1) | MXPA02007295A (es) |
NO (1) | NO20023567L (es) |
PL (1) | PL357017A1 (es) |
WO (1) | WO2001055086A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI311133B (en) * | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
JPWO2003016265A1 (ja) | 2001-08-17 | 2004-12-02 | エーザイ株式会社 | 環状化合物およびpparアゴニスト |
US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
EP1438283A1 (en) * | 2001-10-17 | 2004-07-21 | Novo Nordisk A/S | Dicarboxylic acid derivatives, their preparation and therapeutic use |
ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
CN1688540A (zh) * | 2002-09-05 | 2005-10-26 | 诺沃挪第克公司 | 新颖的乙烯基羧酸衍生物以及它们的治疗用途 |
WO2005105736A1 (en) | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
US20090042781A1 (en) * | 2004-06-28 | 2009-02-12 | Novo Nordisk A/S | Methods for Treating Diabetes |
EA201101085A1 (ru) | 2005-12-22 | 2012-05-30 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Феноксиуксусные кислоты в качестве активаторов ppar дельта |
CA3005158A1 (en) | 2014-11-06 | 2016-05-12 | Scholar Rock, Inc. | Anti-pro/latent-myostatin antibodies and uses thereof |
CN113896789A (zh) | 2015-09-15 | 2022-01-07 | 供石公司 | 抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其用途 |
EP4218817A3 (en) * | 2017-01-06 | 2023-09-06 | Scholar Rock, Inc. | Methods for treating metabolic diseases by inhibiting myostatin activation |
JP2023534835A (ja) | 2020-07-22 | 2023-08-14 | レネオ ファーマシューティカルズ,インク. | 結晶性pparデルタアゴニスト |
WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL176885B1 (pl) * | 1992-07-03 | 1999-08-31 | Smithkline Beecham Plc | Kompozycja farmaceutyczna |
FR2707989B1 (fr) * | 1993-07-22 | 1995-10-13 | Pf Medicament | Nouveaux dérivés de benzylamines silylées, leurs sels, leurs procédés de fabrication et les compositions pharmaceutiques les renfermant. |
BR9508468A (pt) * | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
-
2001
- 2001-01-26 CN CN01804239A patent/CN1396904A/zh active Pending
- 2001-01-26 KR KR1020027009399A patent/KR20020090211A/ko not_active Application Discontinuation
- 2001-01-26 IL IL15025901A patent/IL150259A0/xx unknown
- 2001-01-26 EP EP01946845A patent/EP1254102A1/en not_active Withdrawn
- 2001-01-26 CA CA002396372A patent/CA2396372A1/en not_active Abandoned
- 2001-01-26 WO PCT/DK2001/000057 patent/WO2001055086A1/en not_active Application Discontinuation
- 2001-01-26 MX MXPA02007295A patent/MXPA02007295A/es unknown
- 2001-01-26 BR BR0107902-6A patent/BR0107902A/pt not_active IP Right Cessation
- 2001-01-26 HU HU0204247A patent/HUP0204247A3/hu unknown
- 2001-01-26 AU AU28318/01A patent/AU2831801A/en not_active Abandoned
- 2001-01-26 JP JP2001555029A patent/JP2003520839A/ja active Pending
- 2001-01-26 PL PL01357017A patent/PL357017A1/xx not_active Application Discontinuation
-
2002
- 2002-07-26 NO NO20023567A patent/NO20023567L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20023567D0 (no) | 2002-07-26 |
WO2001055086A1 (en) | 2001-08-02 |
HUP0204247A3 (en) | 2003-10-28 |
MXPA02007295A (es) | 2002-11-29 |
JP2003520839A (ja) | 2003-07-08 |
HUP0204247A2 (hu) | 2003-04-28 |
BR0107902A (pt) | 2002-11-05 |
EP1254102A1 (en) | 2002-11-06 |
NO20023567L (no) | 2002-09-25 |
AU2831801A (en) | 2001-08-07 |
IL150259A0 (en) | 2002-12-01 |
PL357017A1 (en) | 2004-07-12 |
CN1396904A (zh) | 2003-02-12 |
CA2396372A1 (en) | 2001-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6569901B2 (en) | Alkynyl-substituted propionic acid derivatives, their preparation and use | |
KR20050036876A (ko) | 디카르복실산 유도체, 그것의 제제 및 치료에의 사용 | |
CA2367356A1 (en) | New compounds, their preparation and use | |
US20030171358A1 (en) | New compounds, their preparation and use | |
JP2003520838A (ja) | 新規化合物、それらの製造および使用。 | |
KR20020090211A (ko) | 알키닐 치환된 프로피온산 유도체 및 당뇨병 및 비만에대한 그것의 사용 | |
JP2004536150A (ja) | 新規なビニル、カルボン酸誘導体および抗生物質などとしてのそれらの使用 | |
JP4981662B2 (ja) | 新規の化合物、その製法と使用 | |
US6555577B1 (en) | Compounds, their preparation and use | |
US6869967B2 (en) | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives | |
JP2004536152A (ja) | 新規ビニルn−(2−ベンゾイルフェニル)−l−チロシン誘導体及び抗糖尿病剤等へのそれらの使用 | |
US6972294B1 (en) | Compounds, their preparation and use | |
US7067530B2 (en) | Compounds, their preparation and use | |
US7220877B2 (en) | Compounds, their preparation and use | |
US6509374B2 (en) | Compounds, their preparation and use | |
JP2005503377A (ja) | 新規ビニルn−(2−ベンゾイルフェニル)−l−チロシン誘導体及び抗糖尿病剤等へのそれらの使用 | |
US20030055076A1 (en) | Novel compounds, their preparation and use | |
MXPA01010609A (es) | Compuestos nuevos para el tratamiento y/o prevencion de comdiciones mediadas por receptores nucleares, su preparacion y uso de los mismos | |
AU2002316815A1 (en) | Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |